US Drug Recall Register
Class III · Low risk Terminated Initiated Sep 5, 2017 (9 years ago)

ENALAPRIL MALEATE Tablets

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Impurities/Degradation Specifications: manufacturer of product recalled this repackaged lot due to out of specification results for related compound.

What was recalled

ENALAPRIL MALEATE Tablets, USP, 5MG, 90-count bottles, Rx only, MFG: Wockhardt Ltd., India; Packaged By: Aidarex Pharmaceuticals; NDC 33261-0693-90.

Recalling firm
Aidarex Pharmaceuticals LLC
NDC code
33261-0693-90
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0053-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Enalapril recalls

See all
Class II · Moderate risk Ongoing

Enalapril Maleate Tablets

Reason Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test

JB Chemicals and Pharmaceuticals Ltd NDC 64980-688-10 D-0520-2026
Class II · Moderate risk Ongoing

Enalapril Maleate Tablets

Reason CGMP Deviations

Golden State Medical Supply Inc. NDC 60429-186-90 D-1180-2022
Class II · Moderate risk Ongoing

Enalapril Maleate Tablets

Reason CGMP Deviations

Golden State Medical Supply Inc. NDC 60429-185-90 D-1179-2022
Class II · Moderate risk Ongoing

Enalapril Maleate Tablets

Reason CGMP Deviations

Golden State Medical Supply Inc. NDC 60429-184-90 D-1178-2022
Class II · Moderate risk Ongoing

Enalapril Maleate Tablets

Reason CGMP Deviations

Golden State Medical Supply Inc. NDC 60429-183-90 D-1177-2022